AI MARKET SCANNING

$BIVI

BioVie Inc.

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP-2.13%
MAX GAP RECORD-9.44%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

QUANTITATIVE LIVE RADAR BLOTTER

Institutional execution stream for $BIVI

EXECUTIONS2 LOGS
WIN RATE••.•%
NET ROI+•••.••%
Execution DateStrategy & SetupDirectionExecution RangeHold TimeExit TriggerNet PnL
2026-08-27QUANT ALGOSELL x5$•••.•• → $•••.••6m🔒 ENCRYPTED-13.29%
••••-••-••🔒 LOCKED••• x•$•••.•• → $•••.••••h ••m🔒 LOCKED+••.••%
🔒 Institutional Data Protected

Exact execution prices, stop-loss triggers, and full trade logs are reserved for PRO members.

UNLOCK FULL BLOTTER

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.2%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild… Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL